Blocking mTORC1 activity by rapamycin leads to impairment of spatial memory retrieval but not acquisition in C57BL/6J mice

Behavioural Brain Research

Volumn 229, Issue 2, 2012, Pages 320-324

  Deli, Alev ^a   Schipany, Katharina ^a   Rosner, Margit ^a   Höger, Harald ^a   Pollak, Arnold ^a   Li, Lin ^a   Hengstschläger, Markus ^a   Lubec, Gert ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Behaviour; Learning; Memory; MTOR signalling; Multiple T maze; Rapamycin

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; PROTEIN S6; RAPAMYCIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; MALE; MAZE TEST; MEMORY; MEMORY CONSOLIDATION; MEMORY RETRIEVAL; MOUSE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; ROTAROD TEST; SPATIAL MEMORY;

ANIMALS; ENZYME INHIBITORS; HIPPOCAMPUS; MALE; MAZE LEARNING; MENTAL RECALL; MICE; MOTOR ACTIVITY; PHOSPHORYLATION; PROTEINS; RIBOSOMAL PROTEIN S6; ROTAROD PERFORMANCE TEST; SIROLIMUS;

EID: 84862794788     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.01.017     Document Type: Article

References (46)

1. Bekinschtein P., Katche C., Slipczuk L.N., Igaz L.M., Cammarota M., Izquierdo I., et al. mTOR signaling in the hippocampus is necessary for memory formation. Neurobiol Learn Mem 2007, 87:303-307.
2. Garelick M.G., Kennedy B.K. TOR on the brain. Exp Gerontol 2011, 46:155-163.
3. Hoeffer C.A., Klann E. mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci 2010, 33:67-75.
4. Pignataro G., Capone D., Polichetti G., Vinciguerra A., Gentile A., Di Renzo G., et al. Neuroprotective, immunosuppressant and antineoplastic properties of mTOR inhibitors: current and emerging therapeutic options. Curr Opin Pharmacol 2011, 11:378-394.
5. Santos R.X., Correia S.C., Cardoso S., Carvalho C., Santos M.S., Moreira P.I. Effects of rapamycin and TOR on aging and memory: implications for Alzheimer's disease. J Neurochem 2011, 117:927-936.
6. Swiech L., Perycz M., Malik A., Jaworski J. Role of mTOR in physiology and pathology of the nervous system. Biochim Biophys Acta 2008, 1784:116-132.
7. Casadio A., Martin K.C., Giustetto M., Zhu H., Chen M., Bartsch D., et al. A transient, neuron-wide form of CREB-mediated long-term facilitation can be stabilized at specific synapses by local protein synthesis. Cell 1999, 99:221-237.
8. Schicknick H., Schott B.H., Budinger E., Smalla K.H., Riedel A., Seidenbecher C.I., et al. Dopaminergic modulation of auditory cortex-dependent memory consolidation through mTOR. Cereb Cortex 2008, 18:2646-2658.
9. Tischmeyer W., Schicknick H., Kraus M., Seidenbecher C.I., Staak S., Scheich H., et al. Rapamycin-sensitive signalling in long-term consolidation of auditory cortex-dependent memory. Eur J Neurosci 2003, 18:942-950.
10. Parsons R.G., Gafford G.M., Helmstetter F.J. Translational control via the mammalian target of rapamycin pathway is critical for the formation and stability of long-term fear memory in amygdala neurons. J Neurosci 2006, 26:12977-12983.
11. Blundell J., Kouser M., Powell C.M. Systemic inhibition of mammalian target of rapamycin inhibits fear memory reconsolidation. Neurobiol Learn Mem 2008, 90:28-35.
12. Gafford G.M., Parsons R.G., Helmstetter F.J. Consolidation and reconsolidation of contextual fear memory requires mammalian target of rapamycin-dependent translation in the dorsal hippocampus. Neuroscience 2011, 182:98-104.
13. Sui L., Wang J., Li B.M. Role of the phosphoinositide 3-kinase-Akt-mammalian target of the rapamycin signaling pathway in long-term potentiation and trace fear conditioning memory in rat medial prefrontal cortex. Learn Mem 2008, 15:762-776.
14. Myskiw J.C., Rossato J.I., Bevilaqua L.R., Medina J.H., Izquierdo I., Cammarota M. On the participation of mTOR in recognition memory. Neurobiol Learn Mem 2008, 89:338-351.
15. Belelovsky K., Kaphzan H., Elkobi A., Rosenblum K. Biphasic activation of the mTOR pathway in the gustatory cortex is correlated with and necessary for taste learning. J Neurosci 2009, 29:7424-7431.
16. Cui Y., Zhang X.Q., Cui Y., Xin W.J., Jing J., Liu X.G. Activation of phosphatidylinositol 3-kinase/Akt-mammalian target of rapamycin signaling pathway in the hippocampus is essential for the acquisition of morphine-induced place preference in rats. Neuroscience 2010, 171:134-143.
17. Glover E.M., Ressler K.J., Davis M. Differing effects of systemically administered rapamycin on consolidation and reconsolidation of context vs. cued fear memories. Learn Mem 2010, 17:577-581.
18. Gong R., Park C.S., Abbassi N.R., Tang S.J. Roles of glutamate receptors and the mammalian target of rapamycin (mTOR) signaling pathway in activity-dependent dendritic protein synthesis in hippocampal neurons. J Biol Chem 2006, 281:18802-18815.
19. Ran I., Laplante I., Bourgeois C., Pepin J., Lacaille P., Costa-Mattioli M., et al. Persistent transcription- and translation-dependent long-term potentiation induced by mGluR1 in hippocampal interneurons. J Neurosci 2009, 29:5605-5615.
20. Slipczuk L., Bekinschtein P., Katche C., Cammarota M., Izquierdo I., Medina J.H. BDNF activates mTOR to regulate GluR1 expression required for memory formation. PLoS One 2009, 4:e6007.
21. Gelinas J.N., Banko J.L., Hou L., Sonenberg N., Weeber E.J., Klann E., et al. ERK and mTOR signaling couple beta-adrenergic receptors to translation initiation machinery to gate induction of protein synthesis-dependent long-term potentiation. J Biol Chem 2007, 282:27527-27535.
22. Puighermanal E., Marsicano G., Busquets-Garcia A., Lutz B., Maldonado R., Ozaita A. Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling. Nat Neurosci 2009, 12:1152-1158.
23. Hoeffer C.A., Tang W., Wong H., Santillan A., Patterson R.J., Martinez L.A., et al. Removal of FKBP12 enhances mTOR-Raptor interactions, LTP, memory, and perseverative/repetitive behavior. Neuron 2008, 60:832-845.
24. Stoica L., Zhu P.J., Huang W., Zhou H., Kozma S.C., Costa-Mattioli M. Selective pharmacogenetic inhibition of mammalian target of rapamycin complex I (mTORC1) blocks long-term synaptic plasticity and memory storage. Proc Natl Acad Sci U S A 2011, 108:3791-3796.
25. Kunz J., Hall M.N., Cyclosporin A. FK506 and rapamycin: more than just immunosuppression. Trends Biochem Sci 1993, 18:334-338.
26. Hara K., Maruki Y., Long X., Yoshino K., Oshiro N., Hidayat S., et al. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 2002, 110:177-189.
27. Brown E.J., Albers M.W., Shin T.B., Ichikawa K., Keith C.T., Lane W.S., et al. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 1994, 369:756-758.
28. Leone M., Crowell K.J., Chen J., Jung D., Chiang G.G., Sareth S., et al. The FRB domain of mTOR: NMR solution structure and inhibitor design. Biochemistry 2006, 45:10294-10302.
29. Beretta L., Gingras A.C., Svitkin Y.V., Hall M.N., Sonenberg N. Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. Embo J 1996, 15:658-664.
30. Kim D.H., Sarbassov D.D., Ali S.M., King J.E., Latek R.R., Erdjument-Bromage H., et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 2002, 110:163-175.
31. Guertin D.A., Sabatini D.M. Defining the role of mTOR in cancer. Cancer Cell 2007, 12:9-22.
32. Rosner M., Hanneder M., Siegel N., Valli A., Fuchs C., Hengstschlager M. The mTOR pathway and its role in human genetic diseases. Mutat Res 2008, 659:284-292.
33. Wullschleger S., Loewith R., Hall M.N. TOR signaling in growth and metabolism. Cell 2006, 124:471-484.
34. Yang Q., Guan K.L. Expanding mTOR signaling. Cell Res 2007, 17:666-681.
35. Dann S.G., Selvaraj A., Thomas G. mTOR complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer. Trends Mol Med 2007, 13:252-259.
36. Dash P.K., Orsi S.A., Moore A.N. Spatial memory formation and memory-enhancing effect of glucose involves activation of the tuberous sclerosis complex-mammalian target of rapamycin pathway. J Neurosci 2006, 26:8048-8056.
37. Cammalleri M., Lutjens R., Berton F., King A.R., Simpson C., Francesconi W., et al. Time-restricted role for dendritic activation of the mTOR-p70S6K pathway in the induction of late-phase long-term potentiation in the CA1. Proc Natl Acad Sci U S A 2003, 100:14368-14373.
38. Hou L., Klann E. Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression. J Neurosci 2004, 24:6352-6361.
39. Ehninger D., Han S., Shilyansky C., Zhou Y., Li W., Kwiatkowski D.J., et al. Reversal of learning deficits in a Tsc2± mouse model of tuberous sclerosis. Nat Med 2008, 14:843-848.
40. Qi S., Mizuno M., Yonezawa K., Nawa H., Takei N. Activation of mammalian target of rapamycin signaling in spatial learning. Neurosci Res 2010, 68:88-93.
41. Irwin S. Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacologia 1968, 13:222-257.
42. Weitzdoerfer R., Hoeger H., Engidawork E., Engelmann M., Singewald N., Lubec G., et al. Neuronal nitric oxide synthase knock-out mice show impaired cognitive performance. Nitric Oxide 2004, 10:130-140.
43. Rogers D.C., Jones D.N., Nelson P.R., Jones C.M., Quilter C.A., Robinson T.L., et al. Use of SHIRPA and discriminant analysis to characterise marked differences in the behavioural phenotype of six inbred mouse strains. Behav Brain Res 1999, 105:207-217.
44. Patil S.S., Sunyer B., Hoger H., Lubec G. Evaluation of spatial memory of C57BL/6J and CD1 mice in the Barnes maze, the multiple T-maze and in the Morris water maze. Behavioural brain research 2009, 198:58-68.
45. Pagano M., Draetta G., Jansen-Durr P. Association of cdk2 kinase with the transcription factor E2F during S phase. Science 1992, 255:1144-1147.
46. Ferrando-Miguel R., Rosner M., Freilinger A., Lubec G., Hengstschlager M. Tuberin - a new molecular target in Alzheimer's disease. Neurochem Res 2005, 30:1413-1419.